StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
114
This month
10
This year
15
Publishing Date
2024 - 04 - 09
2
2024 - 04 - 03
3
2023 - 12 - 08
2
2023 - 07 - 25
2
2023 - 01 - 19
2
2022 - 08 - 17
3
2022 - 06 - 07
1
2022 - 04 - 15
1
2022 - 04 - 12
1
2022 - 04 - 05
1
2022 - 03 - 04
1
2022 - 01 - 26
1
2022 - 01 - 18
1
2022 - 01 - 14
1
2022 - 01 - 11
1
2022 - 01 - 05
1
2021 - 12 - 20
1
2021 - 12 - 01
1
2021 - 11 - 22
1
2021 - 11 - 16
1
2021 - 11 - 05
1
2021 - 11 - 04
1
2021 - 10 - 18
1
2021 - 09 - 23
1
2021 - 09 - 21
1
2021 - 09 - 13
1
2021 - 09 - 08
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 07 - 28
2
2021 - 07 - 24
1
2021 - 07 - 21
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 07 - 09
1
2021 - 07 - 07
1
2021 - 06 - 29
1
2021 - 06 - 25
1
2021 - 06 - 11
1
2021 - 06 - 07
1
2021 - 05 - 21
2
2021 - 05 - 17
1
2021 - 05 - 13
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 26
1
2021 - 04 - 14
1
2021 - 04 - 12
1
2021 - 03 - 30
1
2021 - 03 - 27
1
2021 - 03 - 15
1
2021 - 03 - 10
1
2021 - 03 - 04
1
2021 - 02 - 26
1
2021 - 02 - 24
1
2021 - 02 - 18
2
2021 - 02 - 12
1
2020 - 12 - 08
1
2020 - 12 - 04
1
Sector
Commercial services
1
Consumer durables
1
Electronic technology
3
Finance
5
Health technology
114
Industrial services
1
Manufacturing
1
Professional, scientific, and technical services
3
Retail trade
3
Technology services
3
Tags
Acute myeloid leukemia
1
Agreement
1
Alliances
1
Aml
1
Application
3
Approval
4
Biotech-beach
2
Biotechnology
4
Blood
6
Blue
5
Car-t
3
Cardio
1
Cardiovascular
1
Cel
8
Cell
8
Chmp
1
Clinical hold
3
Clinical-trials-phase-ii
3
Collaboration
1
Commercial
5
Commercialization
1
Companies
1
Conference
6
Decades
1
Device
1
Disease
13
Drug
2
Earnings
6
Events
10
Fda
13
Fda-approvals
4
Financial
11
Financial results
7
Gene therapies
12
Gene therapy
14
Genetown
20
Global
3
Health
2
Ipo
6
License
4
Market
7
N/a
36
Offering
3
People
10
Pharm-country
2
Phase 2
2
Positive
2
Presentation
2
Program
2
Report
3
Research
8
Results
18
Review
3
T-cell
3
Therapeutics
5
Therapy
32
Trial
2
Update
3
Year
2
Zynteglo
2
Entities
2seventy bio, inc.
5
Abbott laboratories
1
Abeona therapeutics inc.
2
Adaptimmune therapeutics plc
3
Adverum biotechnologies, inc.
1
Agenus inc.
2
Agios pharmaceuticals, inc.
1
Alkermes plc
1
Alnylam pharmaceuticals, inc.
3
Amgen inc.
1
Applied genetic technologies corporation
4
Aravive, inc.
1
Arvinas, inc.
2
Assembly biosciences, inc.
1
Autolus therapeutics plc
3
Avrobio, inc.
1
Becton, dickinson and company
1
Biogen inc.
3
Biolinerx ltd.
1
Black diamond therapeutics, inc.
1
Bluebird bio, inc.
114
Boston scientific corporation
4
Bristol-myers squibb company
8
Cellectis s.a.
3
Charles river laboratories international, inc.
1
Checkpoint therapeutics, inc.
1
Codiak biosciences, inc.
1
Crispr therapeutics ag
3
Danaher corporation
1
Dick's sporting goods inc
3
Editas medicine, inc.
3
Eli lilly and company
1
Evolv technologies holdings inc - class a
1
Exact sciences corporation
1
Exelixis, inc.
2
Federal realty investment trust
1
Forma therapeutics holdings, inc.
1
Gilead sciences, inc.
4
Glaxosmithkline plc
1
Global blood therapeutics, inc.
1
Globe life inc.
1
Ibio, inc.
2
Incyte corporation
2
Inhibrx, inc.
3
Innodata inc.
2
Intellia therapeutics, inc.
3
Johnson & johnson
4
Lonza group ag
2
Luna innovations incorporated
3
Novartis ag
11
Orchard therapeutics plc
3
Precision biosciences, inc.
2
Regenxbio inc.
2
Sangamo therapeutics, inc.
3
Sanofi
4
Sarepta therapeutics, inc.
4
Tcr2 therapeutics inc.
2
Thermo fisher scientific inc
3
Uniqure n.v.
7
Vericel corporation
3
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1622
VZ
1213
XYF
676
Exchanges
Amex
2
Nasdaq
114
Nyse
32
Crawled Date
2024 - 04 - 03
3
2023 - 12 - 08
2
2023 - 07 - 25
2
2023 - 01 - 19
2
2022 - 08 - 17
3
2022 - 06 - 09
1
2022 - 06 - 07
1
2022 - 04 - 15
1
2022 - 04 - 12
1
2022 - 04 - 05
1
2022 - 03 - 04
1
2022 - 01 - 26
1
2022 - 01 - 18
1
2022 - 01 - 14
1
2022 - 01 - 11
1
2022 - 01 - 05
1
2021 - 12 - 20
1
2021 - 12 - 01
1
2021 - 11 - 22
1
2021 - 11 - 16
1
2021 - 11 - 05
1
2021 - 11 - 04
1
2021 - 10 - 18
1
2021 - 09 - 23
1
2021 - 09 - 22
1
2021 - 09 - 13
1
2021 - 09 - 08
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 07 - 30
1
2021 - 07 - 28
2
2021 - 07 - 24
1
2021 - 07 - 21
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 07 - 09
1
2021 - 07 - 07
1
2021 - 06 - 29
1
2021 - 06 - 25
1
2021 - 06 - 11
1
2021 - 06 - 07
1
2021 - 05 - 21
2
2021 - 05 - 17
1
2021 - 05 - 13
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 26
1
2021 - 04 - 14
1
2021 - 04 - 12
1
2021 - 03 - 30
1
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 10
1
2021 - 03 - 04
1
2021 - 02 - 26
1
2021 - 02 - 25
1
2021 - 02 - 18
2
2021 - 02 - 13
1
2020 - 12 - 08
1
2020 - 12 - 04
1
Crawled Time
00:00
2
00:12
1
01:00
3
02:00
1
04:20
1
05:11
1
07:00
1
08:00
2
09:00
1
10:41
1
11:00
7
12:00
17
12:15
1
12:20
1
12:30
2
12:39
1
13:00
15
13:20
2
13:30
7
14:00
8
14:15
1
14:20
2
14:30
1
15:00
3
15:30
1
16:00
2
17:00
2
17:11
1
18:00
5
19:00
2
20:00
4
21:00
2
22:00
9
22:13
1
23:00
3
Source
www.biospace.com
78
www.globenewswire.com
3
www.prnewswire.com
32
www.vbivaccines.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Blue
save search
TOP RANKED ROSEN LAW FIRM Encourages Globe Life Inc. Investors to Inquire About Securities Class Action Investigation - GL
Published:
2024-04-12
(Crawled : 22:00)
- prnewswire.com
GL
|
News
|
$66.74
2.68%
0.03%
3.1M
|
Finance
|
Email alert
Add to watchlist
OCGN
|
News
A
|
$1.315
-0.38%
-0.38%
6.5M
|
Health Technology
|
Email alert
Add to watchlist
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
Email alert
Add to watchlist
life
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-20.17%
|
O:
1.68%
H:
1.65%
C:
-4.13%
nasdaq
grants
CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published:
2024-04-09
(Crawled : 00:00)
- prnewswire.com
LUNA
|
$2.78
-0.71%
-0.72%
1.1M
|
Electronic Technology
|
-3.83%
|
O:
-0.7%
H:
0.0%
C:
-1.4%
CKPT
|
$1.47
-8.13%
-8.84%
760K
|
Health Technology
|
-7.65%
|
O:
-1.64%
H:
1.67%
C:
-1.11%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-17.39%
|
O:
5.22%
H:
0.0%
C:
-1.65%
LUNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luna Innovations Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published:
2024-04-09
(Crawled : 08:00)
- prnewswire.com
LUNA
|
$2.78
-0.71%
-0.72%
1.1M
|
Electronic Technology
|
-6.12%
|
O:
-2.72%
H:
2.8%
C:
0.35%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-23.39%
|
O:
-7.26%
H:
0.0%
C:
0.0%
BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published:
2024-04-05
(Crawled : 14:00)
- prnewswire.com
LUNA
|
$2.78
-0.71%
-0.72%
1.1M
|
Electronic Technology
|
-8.91%
|
O:
-4.29%
H:
2.07%
C:
0.69%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-22.76%
|
O:
-1.63%
H:
4.55%
C:
1.65%
blue
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Published:
2024-04-04
(Crawled : 21:00)
- prnewswire.com
INVZ
|
News
|
$1.01
-4.72%
-4.95%
2M
|
|
-27.03%
|
O:
-1.35%
H:
2.74%
C:
0.0%
WRLD
|
$133.77
1.09%
1.08%
26K
|
Finance
|
-4.57%
|
O:
-1.4%
H:
3.04%
C:
3.04%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-22.76%
|
O:
-1.63%
H:
4.55%
C:
1.65%
blue
bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
Published:
2024-04-03
(Crawled : 13:30)
- prnewswire.com
DKS
|
$195.08
-0.07%
0.0%
720K
|
Retail Trade
|
-8.44%
|
O:
-0.14%
H:
0.0%
C:
0.0%
INOD
|
$5.8
-1.02%
-1.03%
260K
|
Technology Services
|
-12.57%
|
O:
-0.89%
H:
9.55%
C:
6.27%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-21.49%
|
O:
-2.48%
H:
3.39%
C:
0.0%
blue
Investors who lost money on DICK's Sporting Goods(DKS) should contact Levi & Korsinsky about pending Class Action - DKS
Published:
2024-04-03
(Crawled : 13:30)
- prnewswire.com
DKS
|
$195.08
-0.07%
0.0%
720K
|
Retail Trade
|
-8.44%
|
O:
-0.14%
H:
0.0%
C:
0.0%
INOD
|
$5.8
-1.02%
-1.03%
260K
|
Technology Services
|
-12.57%
|
O:
-0.89%
H:
9.55%
C:
6.27%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-21.49%
|
O:
-2.48%
H:
3.39%
C:
0.0%
Evolv Technologies Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EVLV
Published:
2024-04-03
(Crawled : 13:30)
- prnewswire.com
EVLV
|
$3.835
-2.67%
-2.74%
920K
|
|
-22.06%
|
O:
-2.08%
H:
2.42%
C:
-2.22%
DKS
|
$195.08
-0.07%
0.0%
720K
|
Retail Trade
|
-8.44%
|
O:
-0.14%
H:
0.0%
C:
0.0%
IESC
|
$115.44
-0.37%
-0.37%
120K
|
Industrial Services
|
-6.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-21.49%
|
O:
-2.48%
H:
3.39%
C:
0.0%
BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published:
2024-04-01
(Crawled : 23:00)
- prnewswire.com
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-23.39%
|
O:
-1.61%
H:
2.46%
C:
-0.82%
blue
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
Published:
2024-03-26
(Crawled : 12:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-30.15%
|
O:
-12.87%
H:
2.11%
C:
1.27%
results
bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
Published:
2024-03-18
(Crawled : 15:30)
- biospace.com/
HTGC
F
|
$18.46
1.15%
0.38%
660K
|
Finance
|
0.5%
|
O:
0.28%
H:
0.39%
C:
-0.5%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-33.1%
|
O:
2.11%
H:
6.55%
C:
-0.69%
million
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-36.67%
|
O:
7.33%
H:
3.1%
C:
-13.66%
first
disease
cell
agreement
therapy
Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published:
2024-01-12
(Crawled : 22:00)
- prnewswire.com
TGTX
|
News
|
$13.79
-1.43%
-1.45%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
RARE
F
|
$42.37
-2.33%
-2.38%
680K
|
Health Technology
|
Email alert
Add to watchlist
SLDB
|
$8.7
-6.05%
-6.44%
110K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
Email alert
Add to watchlist
global
therapy
market
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
Published:
2024-01-08
(Crawled : 18:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-33.1%
|
O:
0.7%
H:
3.85%
C:
2.8%
update
commercial
program
financial
Autolus Therapeutics Announces Changes to its Board of Directors
Published:
2023-12-22
(Crawled : 12:00)
- globenewswire.com
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-30.66%
|
O:
1.46%
H:
4.32%
C:
0.72%
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
-13.83%
|
O:
1.06%
H:
3.51%
C:
-0.35%
therapeutics
bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
Published:
2023-12-20
(Crawled : 09:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-60.91%
|
O:
-46.3%
H:
7.28%
C:
1.15%
offering
bluebird bio Details Plans for the Commercial Launch of LYFGENIA™ Gene Therapy for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Published:
2023-12-08
(Crawled : 22:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-80.25%
|
O:
6.03%
H:
8.43%
C:
-43.92%
disease
cell
commercial
therapy
bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Published:
2023-12-08
(Crawled : 22:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-80.25%
|
O:
6.03%
H:
8.43%
C:
-43.92%
fda
disease
approval
cell
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
Published:
2023-11-07
(Crawled : 16:00)
- biospace.com/
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-71.21%
|
O:
4.24%
H:
3.2%
C:
2.91%
financial
results
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
News
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.